PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29364494-0	2018	Oxcarbazepine causes neurocyte apoptosis and developing brain damage by triggering Bax/Bcl-2 signaling pathway mediated caspase 3 activation in neonatal rats.	Oxcarbazepine	0-13	BCL2 associated X, apoptosis regulator	Rattus norvegicus	83-86	
29364494-13	2018	OXC 281.25 mg/kg and OXC 375 mg/kg significantly increased Bax, Bax/Bcl-2 ratio and cytochrome C release in frontal lobes compared to Control group in P5 rats (p<0.05).	Oxcarbazepine	0-3	BCL2 associated X, apoptosis regulator	Rattus norvegicus	59-62	
29364494-13	2018	OXC 281.25 mg/kg and OXC 375 mg/kg significantly increased Bax, Bax/Bcl-2 ratio and cytochrome C release in frontal lobes compared to Control group in P5 rats (p<0.05).	Oxcarbazepine	0-3	BCL2 associated X, apoptosis regulator	Rattus norvegicus	64-67	
29364494-13	2018	OXC 281.25 mg/kg and OXC 375 mg/kg significantly increased Bax, Bax/Bcl-2 ratio and cytochrome C release in frontal lobes compared to Control group in P5 rats (p<0.05).	Oxcarbazepine	21-24	BCL2 associated X, apoptosis regulator	Rattus norvegicus	59-62	
29364494-13	2018	OXC 281.25 mg/kg and OXC 375 mg/kg significantly increased Bax, Bax/Bcl-2 ratio and cytochrome C release in frontal lobes compared to Control group in P5 rats (p<0.05).	Oxcarbazepine	21-24	BCL2 associated X, apoptosis regulator	Rattus norvegicus	64-67	
29364494-14	2018	CONCLUSIONS: Oxcarbazepine at a concentration of 281.25 mg/kg or more causes neurocyte apoptosis and developing brain damage by triggering Bax/Bcl-2 signaling pathway mediated caspase 3 activation in neonatal rats.	Oxcarbazepine	13-26	BCL2 associated X, apoptosis regulator	Rattus norvegicus	139-142